Cellebration’s Chief Scientific Officer, Dr. Anand Srivastava, along with many members of GIOSTAR’s Medical Advisory Board, have published many peer-reviewed articles in prestigious medical and science publications.
Cardiovascular diseases: Recent developments in regenerative medicine. Mahmood, A., Pandya, H., Rajasekar,S., Patel, D., Srivastava A.. Journal of Stem Cell Research & Therapeutics. 2017, July 3(2):00095. doi: 10.15406/jsrt.2017.03.00095.
Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice. Sharma V, Nayak J, DeRossi C, Charbono A, Ichikawa M, Ng BG, Grajales-Esquivel E, Srivastava A, Wang L, He P, Scott DA, Russell J, Contreras E, Guess CM, Krajewski S, Del Rio-Tsonis K, Freeze HH. FASEB J. 2014 Apr 28(4):1854-69. doi: 10.1096/fj.13-245514.
Basal expression of pluripotency-associated genes can contribute to stemness property and differentiation potential. Dadheech N, Srivastava A, Belani M, Gupta S, Pal R, Bhonde RR, Srivastava AS, Gupta S. Stem Cells Dev. 2013 Jun 15;22(12):1802-17. doi: 10.1089/scd.2012.0261.
Therapeutic potential of mesenchymal stem cells in regenerative medicine. Patel DM, Shah J, Srivastava AS., Stem Cells Int. 2013 Feb 496218. doi: 10.1155 / 2013 / 496218.
Kim J, Vasu VT, Mishra R, Singleton KR, Yoo M, Leach SM, Farias-Hesson E, Mason RJ, Kang J, Ramamoorthy P, Kern JA, Heasley LE, Finigan JH, Tan AC. Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy. Bioinformatics. 30:2393-8 (2014).
inigan JH, Vasu VT, Thaikoottathil JV, Mishra R, Shatat MA, Mason RJ, Kern JA. HER2 activation results in β-catenin-dependent changes in pulmonary epithelial permeability. Am J Physiol Lung Cell Mol Physiol. 2015 Jan 15;308(2):L199-207. doi: 10.1152/ajplung.00237.2014. Epub 2014 Oct 17.
Singh, U.P., Narendra P. Singh, Balwan Singh, Lorne J. Hofseth, Robert L Price, Mitzi Nagarkatti, and Prakash S. Nagarkatti. (2011) Role of resveratrol-induced CD11b+ Gr-1+ myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3+ T cells and amelioration of chronic colitis in IL-10-/- mice. (Accepted in Brain, Behavior and Immunity).
Singh, U.P.*, Narendra P. Singh*, Balwan Singh, Robert L Price, Mitzi Nagarkatti,and Prakash S. Nagarkatti. (2011) Activation of Aryl Hydrocarbon Receptor Leads to Reciprocal Epigenetic Regulation of FoxP3 and IL-17 genes and Amelioration of Experimental Colitis. (Accepted in PLoS ONE).
Singh, U.P., Narendra P. Singh, Balwan Singh, Lorne J. Hofseth, Robert L Price,Mitzi Nagarkatti, and Prakash S. Nagarkatti (2010) Resveratrol (trans-3, 5, 4′- trihydroxystilbene) induces SIRT1 and down-regulates NF-kB activation toabrogate DSS-induced colitis. J. Pharmacology & Exp. Therapeutics. 332(3): 829-839.
Xiangli Cui, Yu Jin, Anne B. Hofseth, Alexander Chumanevich, Mitzi Nagarkatti,Prakash S. Nagarkatti, Udai P. Singh, and Lorne J. Hofseth (2010) Resveratrolsuppresses colitis and colon cancer associated with colitis. Cancer-Prevention Research. 3(4): 549-559.
Singh, U.P., Narendra P. Singh, Balwan Singh, Mishra Manoj, Mitzi Nagarkatti, Prakash S. Nagarkatti and Singh SR (2010) Stem cells as potential therapeutic targets for Inflammatory Bowel Disease. Frontiers in Biosciences S (2): 993-1008.
Lorne J. Hofseth, Singh, U.P., Narendra P. Singh, Mitzi Nagarkatti, and Prakash S. Nagarkatti (2010) Taming the beast within: resveratrol suppresses colitis and prevents colon cancer. Aging 2(4): 183-184.
Yu Jin, Xiangli Cui, Udai P. Singh, Brook Harmon, Philip Cavicchia, Anne B. Hofseth, Venkata Kotakadi, Brandy Stroud, Alexander A. Chumanevich,James R. Hebert, Thomas G. Hurley, and Lorne J. Hofseth (2010) Systemic inflammatory load in humans is suppressed by consumption of two formulations of dried, encapsulated juice concentrate. Molecular Nutrition and Food Research (54): 1-9.
Singh U.P., Singh, R., Singh, S., Karls R.K., Quinn F.D., Taub, D.D., and J.W. Lillard, Jr. (2008) CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. BMC Immunol. 9(1): 25.
Singh U.P.*, Sakthivel, S.K.*, Singh, S., Taub, D.D., Igietseme, J.U., and J.W. Lillard, Jr. (2008) CCL5 regulation of mucosal chlamydial immunity and infection. BMC Microbiol. 8:136.
Singh U.P.*, Sakthivel, S.K.*, Singh, S., Taub, D.D., Kristian R Novakovic, and J.W. Lillard, Jr. (2008) CXCL10-blockade protects mice from cyclophosphamide- induced cystitis. J immune Based Ther Vaccines. 6(1): 6.
Singh U.P., Singh, S., Singh, R., Cong, Y., Taub, D.D. and J.W. Lillard, Jr. (2008) Chronic colitis and CXCL10-producing mucosal T helper, NK and NKT cells in IL10-/- mice can be abrogated by CXCL10 blockade. Journal of Interferon and Cytokine Research. 28(1): 31-43.
Singh U.P., A. Krishna, and Kunwar P. Bhatnagar (2008) Changes in serum leptin, insulin, androstenedione, and luteinizing hormone during ovarian cycle in the bat, Taphozous longimanus. Acta Biologica Hungarica. 59(1): 1-16.* Indicate equal contribution
Singh U.P., Singh S, Chandrasekar Venkataraman and James W. Lillard, Jr. (2007) CXCR3 Axis: Role in Inflammatory Bowel Disease and its Therapeutic Implication. Endocrine, Metabolic & Immune Disorder: Drug Target. 7(2): 111- 123.
Singh U.P., Singh S, Singh R, Frederick D. Quinn, Morris E. Potter & James W. Lillard, Jr. (2007) Influence of Mycobacterium avium paratuberculosis on colitis development and specifics immune responses during disease. Infection and Immunity. 75 (8): 3722-3278.